Investment Rating - The investment rating for the company is "Buy" and "Maintain" [6] Core Views - The company has turned a profit due to improved asset impairment, with a net profit of 462.63 million RMB in 2025, a year-on-year increase of 105.85% [1][2] - The company is a leader in the lithium resource industry, maintaining a positive outlook despite lower lithium prices than expected [1][5] - The company has plans to expand its lithium chemical product capacity to a total of 122,600 tons per year [3] Financial Performance - In 2025, the company achieved revenue of 10.346 billion RMB, a decrease of 20.80% year-on-year, while the net profit was 462.63 million RMB, reflecting a significant recovery [1][10] - Investment income improved from a loss of 643 million RMB in 2024 to a profit of 529 million RMB in 2025 [2] - The company’s net profit forecast for 2026 and 2027 has been significantly raised to 6.097 billion RMB and 7.712 billion RMB, respectively, reflecting an increase of 115.7% and 117.1% compared to previous estimates [5][10] Market Outlook - The global supply-demand balance for lithium carbonate is expected to remain tight, driven by strong demand from electric vehicles and energy storage [4] - The company is actively working on expanding its lithium mining resources, which will support future growth [3] Valuation - The target price for the company is set at 84.25 RMB, based on a PE ratio of 23.6 for 2026, reflecting an increase from the previous target of 68.3 RMB [5][6] - The H-share target price is set at 73.99 HKD, up from 64.24 HKD, considering the recent average A/H premium rate of 28.9% [5][6]

Investment Rating - The report maintains an "Accumulate" rating for both A and H shares of the company [8] Core Views - The company reported a total revenue of 2,864.5 billion RMB for 2025, a decrease of 2.5% year-on-year, with a net profit attributable to shareholders of 157.3 billion RMB, down 4.5% year-on-year [1] - The company’s Q4 revenue was 695.2 billion RMB, showing a quarter-on-quarter change of +2.2% and a year-on-year change of -3.3% [1] - The dividend per share for the year is set at 0.25 RMB, leading to a total cash dividend payout ratio of 54.7%, an increase of 2.5 percentage points from 2024 [1] - The report anticipates an increase in oil prices due to geopolitical factors, alongside continued growth in the company's natural gas business, justifying the "Accumulate" rating [6] Revenue and Profit Analysis - The company’s crude oil production increased by 0.7% to 948 million barrels, while the average selling price decreased by 14.2% to 64.11 USD per barrel [2] - The natural gas sales volume rose by 4.5% to 5,363.2 billion cubic feet, with unit operating costs remaining stable at 12.04 USD per barrel [2] - The operating profit from the oil and gas segment decreased by 14.8% to 136.07 billion RMB due to falling international oil prices [2] Refining and Chemical Business - The company processed 1,375.9 million barrels of crude oil, a slight decrease of 0.2%, with gasoline and diesel production down by 5.7% and 3.2%, respectively [3] - The refining segment's operating profit increased by 13.4% to 24.25 billion RMB, driven by higher refining margins [3] - Key projects in refining and chemical transformation are progressing steadily, including upgrades at Jilin and Guangxi Petrochemical [3] Sales and Marketing Performance - Total refined oil sales reached 16,081 million tons, a slight increase of 1.1%, while domestic sales fell by 0.4% [4] - The marketing segment's operating profit grew by 6.4% to 17.55 billion RMB, attributed to increased profits from LNG and charging services [4] Natural Gas Segment - The company sold 3,147 billion cubic meters of natural gas, a year-on-year increase of 7.0%, with domestic sales up by 5.6% [5] - The natural gas segment's operating profit rose by 12.6% to 60.8 billion RMB, driven by effective cost control and optimized resource allocation [5] Profit Forecast and Valuation - The report projects crude oil prices to rise to 84, 75, and 70 USD per barrel for 2026-2028, respectively, and raises the net profit forecast for 2026 to 199.1 billion RMB [6] - The target prices for A and H shares are set at 15.81 RMB and 13.63 HKD, respectively, reflecting a price-to-earnings ratio of 14.5x for A shares and 11.0x for H shares [6]

Investment Rating - The report maintains a "Buy" rating for the company with a target price of HKD 37.36 [1]. Core Insights - The company achieved a revenue of CNY 3.001 billion in 2025, representing a year-on-year increase of 16.7%, and a net profit attributable to shareholders of CNY 318 million, up 39.0%, which aligns with expectations [6]. - The company continues to show strong fundamentals, with same-store sales growth of 6.9% and a high dividend payout ratio, with a year-end dividend of HKD 0.72 per share [6]. - The company is positioned as a leader in the beauty and health chain service sector, benefiting from a "dual beauty + dual healthcare" strategy, and is expected to leverage high-end consumption recovery trends for mid-term growth [6][10]. Financial Performance - Revenue projections for 2026 and 2027 have been revised upwards to CNY 39.15 billion and CNY 43.15 billion, respectively, reflecting increases of 18.6% and 21.5% [10]. - The company’s gross margin improved to 49.1% in 2025, up 2.8 percentage points year-on-year, driven by cost optimization and acquisitions [8]. - Operating cash flow for 2025 reached CNY 1.0 billion, marking a 25.4% increase year-on-year, demonstrating strong cash generation capabilities [9]. Business Segments - The beauty and wellness services segment generated revenue of CNY 1.658 billion in 2025, up 14.9%, with direct and franchise income growing by 15.8% and 5.9%, respectively [7]. - The medical beauty services segment reported revenue of CNY 1.017 billion, a year-on-year increase of 9.6%, with significant growth in customer traffic and average spending [7]. - The sub-health medical services segment saw remarkable growth, achieving revenue of CNY 326 million, up 62.2%, contributing to 10.9% of total revenue [7]. Valuation Metrics - The company’s projected PE ratio for 2026 is set at 19 times, reflecting its leading position in the beauty chain sector and expected growth from both organic and acquisition strategies [10]. - The report indicates a projected EPS of CNY 1.76 for 2026, with a continued focus on enhancing profitability through operational efficiencies [10].

Investment Rating - The report maintains an "Accumulate" rating for the company [7][5]. Core Views - The company is expected to continue its operational resilience, driven by a dual engine of "catering + food" and solid performance in its core business segments [1][2]. - The company has shown a commitment to shareholder returns, with a proposed dividend of 4 RMB per 10 shares, resulting in a dividend payout ratio of 58.03% [1][3]. Financial Performance - In 2025, the company achieved a revenue of 5.382 billion RMB, representing a year-over-year increase of 5.04%, while the net profit attributable to shareholders was 488 million RMB, down 1.19% year-over-year [1][11]. - The food manufacturing segment generated revenue of 3.754 billion RMB, accounting for 69.76% of total revenue, with a gross margin of 38.30%, an increase of 0.49 percentage points year-over-year [2][11]. - The catering business reported revenue of 1.539 billion RMB, up 5.79% year-over-year, with a total of 56 direct-operated restaurants by the end of 2025 [2][11]. Market Expansion and Strategy - The company is making steady progress in expanding its production capacity outside Guangdong province, achieving 1.093 billion RMB in revenue from regions outside the province, a year-over-year increase of 9.37% [3][11]. - The company is actively pursuing international markets, including Hong Kong, Macau, and North America, while implementing an integrated online and offline sales strategy [3][11]. Cost Management and Efficiency - The company has optimized its cost management, with sales, management, and R&D expense ratios at 10.11%, 8.50%, and 1.45%, respectively [4][11]. - The increase in sales expense ratio is attributed to enhanced brand promotion and marketing efforts, while management expenses have been optimized through internal cost control measures [4][11]. Profit Forecast and Valuation - The forecast for net profit attributable to shareholders for 2026 and 2027 is adjusted to 507.68 million RMB and 553.25 million RMB, respectively [5][11]. - The target price is set at 17.83 RMB, reflecting a valuation based on the food and catering segments [5][11].

Investment Rating - The investment rating for the company is "Buy" with a target price of HKD 3.96 [6][11]. Core Insights - The company's revenue for the year 2025 was CNY 1.986 billion, a year-on-year decrease of 4.6%, which was slightly below the expected CNY 2.077 billion. The adjusted net profit was CNY 142 million, down 16.6% year-on-year, also below the expected CNY 231 million. The decline in revenue was primarily due to the incomplete recovery of demand for mid-to-high-end white-collar recruitment, although the decline narrowed quarter by quarter. Cash collections turned positive year-on-year in the second half of the year, and revenue growth is expected to turn positive in 2026. The profit decline was significantly impacted by overseas financial management income, but adjusted operating profit increased by 24.7% year-on-year when excluding interest impacts, reflecting the benefits of AI empowerment and cost reduction [1][3][5]. Summary by Sections Business Performance - The platform's ecosystem remains stable, with 1.474 million verified enterprises and 72,000 paying enterprise clients by the end of 2025, representing year-on-year increases of 3.2% and 5.3%, respectively. B-end revenue was CNY 1.652 billion, down 6.2% year-on-year, but the decline was significantly narrowed, with cash collections turning positive in the second half. C-end revenue was CNY 334 million, up 5.0% year-on-year, achieving growth against a high base [2]. Profitability - The company's gross margin for 2025 was 76.6%, an increase of 0.5 percentage points year-on-year, benefiting from the increased proportion of AI product revenue and improved operational efficiency. Operating expenses were CNY 1.447 billion, down 5.3% year-on-year, with an operating expense ratio of 72.9%, a decrease of 0.6 percentage points. The annual operating profit and net profit attributable to the parent company were CNY 166 million and CNY 103 million, down 13.5% and 23.1% year-on-year, respectively, mainly due to declines in non-recurring income such as financial management income and exchange gains [3][4]. AI Strategy - The company continues to deepen the application of AI technology across the recruitment process, with AI product coverage reaching 93% for enterprise accounts. The "intended candidates" product can deliver candidates for 65% of job orders within 2 hours, and the monthly repeat initiation rate has increased to 66%. The AI job-seeking assistant Dora has significantly activated user engagement, leading to a 15.3% year-on-year increase in average monthly active users, with a total of 116 million registered job seekers, up 10% year-on-year. AI product revenue exceeded CNY 100 million, accounting for 5% of total revenue, marking a transition from technology investment to revenue contribution [4]. Financial Forecast and Valuation - Considering the ongoing recovery in mid-to-high-end recruitment demand, the company has slightly lowered its revenue forecasts for 2026-2027, with new estimates of CNY 2.002 billion, CNY 2.009 billion, and CNY 2.028 billion for 2026, 2027, and 2028, respectively. The adjusted net profit forecasts have been reduced to CNY 148 million, CNY 193 million, and CNY 226 million for the same years. The target price has been adjusted to HKD 3.96, down from HKD 7.38, based on a 12.1x adjusted PE valuation for 2026 [5][11].

Investment Rating - The investment rating for the company is "Buy" [6][2] Core Insights - The company achieved a revenue of 206.68 billion RMB in 2025, a year-on-year decrease of 2.98%, while the net profit attributable to shareholders was 20.34 billion RMB, reflecting a year-on-year increase of 50.30% [2][3] - In Q4 2025, the company reported a revenue of 61.20 billion RMB, a year-on-year increase of 5.02% and a quarter-on-quarter increase of 20.68%, driven by rising metal prices and increased copper sales [2][3] - The company is positioned as a leading copper mining and minor metals enterprise, with plans to expand its gold segment, including acquisitions of significant gold assets [4][3] Revenue and Profit Forecast - The company expects to increase copper production to between 760,000 and 820,000 tons in 2026, with a further expansion planned for 2027 [3][4] - The projected net profit for 2026 is 35.21 billion RMB, with a growth rate of 73.11% compared to 2025 [10][5] - The estimated revenue for 2026 is 225.87 billion RMB, representing a year-on-year growth of 9.28% [10][5] Valuation Metrics - The target price for the A-shares is set at 26.81 RMB, while the target price for the H-shares is 26.26 HKD, reflecting a premium of 35% over comparable companies [5][6] - The estimated PE ratio for 2026 is 16.3x, which is above the average PE of 12.0x for comparable companies [5][11] Production and Expansion Plans - The company’s copper production reached 741,100 tons in 2025, marking a year-on-year increase of 13.99% and placing it among the top ten copper producers globally [3][4] - The company has initiated the construction of a world-class gold asset in Ecuador, expected to commence production in 2029, and has also acquired operational gold mines in Brazil [4][3]

Investment Rating - The investment rating for the company is maintained as "Buy" with a target price of RMB 14.75 [1][4]. Core Views - The report indicates that the product cycle for the company is expected to bottom out and rebound in 2026, maintaining net profit expectations for 2026-2027 [1]. - The company faced revenue declines in 2025 due to weak industry conditions, but managed to offset some price declines through increased sales volume [2]. - The report highlights that the prices of key products such as spandex and adipic acid are showing signs of recovery, which could lead to improved profitability in 2026 [3]. Summary by Sections Financial Performance - In 2025, the company achieved revenue of RMB 24.198 billion, a year-over-year decline of 10.15%, with a net profit of RMB 1.858 billion, down 16.32% year-over-year [1][2]. - The fourth quarter of 2025 saw revenue of RMB 6.089 billion, a decrease of 7.17% year-over-year but an increase of 1.94% quarter-over-quarter [1]. - The gross margins for chemical fibers, new chemical materials, and basic chemicals were 16.5%, 20.6%, and 3.9% respectively, with slight improvements in chemical fibers due to cost control [2]. Product Outlook - The spandex market is expected to see a turning point in 2026, with limited new capacity and potential exit of outdated production, improving supply-demand dynamics [3]. - Adipic acid prices are also anticipated to rebound due to low industry inventory and strong supplier pricing intentions, leading to a better outlook compared to 2025 [3]. Profit Forecast and Valuation - The forecast for net profit for 2026-2028 is RMB 2.93 billion, RMB 3.37 billion, and RMB 3.72 billion respectively, representing year-over-year growth of 57.85%, 14.87%, and 10.32% [4]. - The report assigns a price-to-earnings ratio of 25x for 2026, leading to a target price of RMB 14.75, up from a previous estimate of RMB 11.21 [4].

Investment Rating - The report maintains a "Buy" rating for the company [7] Core Views - The company is expected to see a revenue of 2.649 billion RMB in 2025, a decrease of 5.8% year-over-year, with an adjusted net profit of 209 million RMB, down 49.7% year-over-year. The decline in revenue and profit is attributed to an increase in the proportion of artificial insemination (IUI) affecting the number of egg retrieval cycles and pricing, along with zero markup on drug costs. However, there is a significant improvement expected in the second half of the year [1][5] - For 2026, the company anticipates positive revenue growth driven by the implementation of the California commercial insurance law SB729, which is expected to increase cycle numbers by 38% year-over-year in January-February, and the new Shenzhen facility expected to contribute to an 18% year-over-year increase in cycle numbers [1][2] Summary by Sections Domestic Business - The revenue in the Greater Bay Area is projected to decline by 8.8% to 420 million RMB in 2025, primarily due to a higher proportion of lower-cost IUI cycles and delays in the relocation of the Shenzhen facility. However, for 2026, double-digit year-over-year growth is anticipated in the Shenzhen area due to significant capacity expansion and an expected increase in customer pricing through high-value services [2] Overseas Business - The HRC Fertility business in the U.S. is expected to benefit from the acceleration of commercial insurance coverage, with a revenue increase of 5.1% year-over-year in 2025. For 2026, both revenue and profitability are expected to improve significantly due to the SB729 law, which mandates insurance coverage for infertility diagnosis and treatment for larger companies [3] Steady Domestic Regions - The Chengdu region is expected to achieve positive revenue growth in 2026, supported by a 72.8% year-over-year increase in third-generation IVF cycles in 2025 and a rising proportion of high-value services. The Wuhan and Kunming regions are also projected to continue their steady expansion, with a target of over 5,000 cycles in 2026 [4] Profit Forecast and Valuation - The adjusted EPS for 2026-2028 is forecasted to be 0.11, 0.15, and 0.19 RMB respectively. The report assigns a 26x PE ratio for 2026, with a target price of 3.25 HKD, reflecting a premium over the average 17x PE of comparable companies [5][11]

Investment Rating - The report maintains an "Accumulate" rating for both A and H shares of the company [8] Core Views - The company reported a total revenue of 2,864.5 billion RMB for 2025, a decrease of 2.5% year-on-year, with a net profit attributable to shareholders of 157.3 billion RMB, down 4.5% year-on-year [1][2] - The company’s Q4 revenue was 695.2 billion RMB, showing a quarter-on-quarter change of +2.2% and a year-on-year change of -3.3% [1] - The dividend per share for the year is set at 0.25 RMB, leading to a total cash dividend payout ratio of 54.7%, an increase of 2.5 percentage points from 2024 [1] - The report anticipates an increase in oil prices due to geopolitical factors, which may elevate the mid-term oil price average [6] Revenue and Profit Analysis - The company’s crude oil production increased by 0.7% to 948 million barrels, while the average selling price decreased by 14.2% to 64.11 USD per barrel [2] - The natural gas sales volume rose by 4.5% to 5,363.2 billion cubic feet, with a stable unit operating cost of 12.04 USD per barrel [2] - The refining segment saw a profit increase of 13.4% to 24.25 billion RMB, driven by improved refining margins [3] - The total sales volume of refined oil was 16,081 million tons, with domestic sales slightly declining by 0.4% [4] Natural Gas Segment Performance - The company sold 3,147 billion cubic meters of natural gas, a year-on-year increase of 7.0%, with domestic sales up by 5.6% [5] - The natural gas segment's operating profit grew by 12.6% to 60.8 billion RMB due to effective cost control and optimized resource procurement [5] Future Earnings Forecast - The report projects crude oil prices for 2026-2028 at 84/75/70 USD per barrel, with net profit estimates for 2026 and 2027 raised to 199.1 billion RMB and 194.5 billion RMB, respectively [6] - The expected earnings per share (EPS) for 2026 is 1.09 RMB, with a price-to-earnings (P/E) ratio of 14.5 for A shares and 11.0 for H shares [6] - The target prices are set at 15.81 RMB for A shares and 13.63 HKD for H shares, reflecting an increase from previous estimates [6]

Investment Rating - The investment rating for the company is "Buy" and "Maintain" [6] Core Views - The company has turned a profit due to improved asset impairment, with a net profit of 462.63 million RMB in 2025, a year-on-year increase of 105.85% [1][2] - The company is a leader in the lithium resource industry, maintaining a positive outlook despite lower lithium prices than expected [1] - The company has plans to expand its lithium chemical product capacity to a total of 122,600 tons per year [3] Financial Performance - In 2025, the company achieved revenue of 10.346 billion RMB, a decrease of 20.80% year-on-year, while the net profit was 462.63 million RMB [1][10] - Investment income improved significantly from a loss of 643 million RMB in 2024 to a profit of 529 million RMB in 2025 [2] - The company reported a significant reduction in asset impairment losses from 1.618 billion RMB in 2024 to 258 million RMB in 2025 [2] Future Projections - The company expects its net profit to rise to 6.097 billion RMB in 2026 and 7.712 billion RMB in 2027, reflecting a year-on-year increase of 1,218% and 26.48% respectively [5][10] - The projected earnings per share (EPS) for 2026 is 3.57 RMB, increasing to 4.52 RMB in 2027 and 5.66 RMB in 2028 [5][10] Valuation - The target price for the company's stock is set at 84.25 RMB, based on a price-to-earnings (PE) ratio of 23.6 for 2026 [5] - The company's H-share target price is 73.99 HKD, reflecting an increase from the previous target of 64.24 HKD [5] Market Conditions - The report anticipates a balanced supply-demand scenario for lithium carbonate in 2026, driven by strong demand from electric vehicles and energy storage [4] - The company is well-positioned to benefit from the expected increase in lithium prices due to global supply disruptions and rising demand [4]